NorthWest Biotherapeutics Inc (NWBO)

[Truthfan]

Reference: UCLA Brain Tumor Center - 2.12.2020

Noted as one of the UCLA speakers at this event is Dr. Phioanh Nghiemphu. Dr. Nghiemphu is listed on the Global Coalition for Adaptive Research site as investigator for upcoming UCLA GBM AGILE trial:

“WHAT IS GBM AGILE?
GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) is a flexible and adaptable trial approach that evaluates several treatment arms simultaneously and/or over time, giving it the potential to fundamentally change the clinical research process for glioblastoma (GBM) by identifying or disproving therapies more quickly. This will help to usher in a new generation of effective treatments for GBM, the most common and the deadliest type of brain cancer.”

“Coming Soon!”
University of California, Los Angeles (Los Angeles, CA)

Principal Investigator: Phioanh Nghiemphu, MD

https://www.gcaresearch.org/gbm-agile/trial-sites/

Noted: On the GBM AGILE's Knowledge Network are the names of:
TIMOTHY F. CLOUGHESY, M.D
LINDA LIAU, M.D., PH.D., M.B.A.